Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton Pump Inhibitor for Prevention of Tumor Bleeding in Unresectable Gastric Cancer
NCT02150447Phase 3Terminated
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Jun 2009
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lansoprazole in gastric cancer (GC), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Started Jun 2009; status: terminated.
02
Drugs
lansoprazole
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02150447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150447.